EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieÜbersichtsarbeitOpen Access · CC BY 4.0

Micro-ultrasound guided versus multiparametric MRI-guided prostate biopsy: a systematic review and meta-analysis

Niamh Moynagh, Josh Bruinsma, Benjamin M Mac Curtain, Gavin G Calpin, Mohamed Elfaki, Rostyslav Nikolenko, Avinash Deshwal, Nicholas Clausen, Ali Benour, Wanyang Qian, Hugo C Temperley, Peter Lawlor und 4 weitere

International Urology and Nephrology · 15.06.2026 · 58 (12) · 5131-5141

DOI: 10.1007/s11255-026-05227-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Urology and Nephrology, online erschienen am 15.06.2026. Verfasst von Niamh Moynagh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2, Dublin, Ireland. niamhmoynagh21@rcsi.ie. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Image-Guided Biopsy, Prostate. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Surgeons in Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate patients with suspected prostate cancer, multiparametric MRI (mpMRI) has been the standard imaging modality employed. However, mpMRI is costly and not universally available. Microultrasound (mUS), a novel 29-MHz modality, offers high-resolution, real-time prostate imaging and may guide biopsy with comparable diagnostic accuracy. This systematic review and meta-analysis compares mUS-guided and mpMRI-guided prostate biopsy for the detection of prostate cancer (PCa).

Methods

A systematic search was conducted up to April 2025, in accordance with the PRISMA guidelines (PROSPERO ID CRD420251033768). Comparative studies reporting PCa detection between mUS and mpMRI were included.

Results

Twelve studies comprising 4318 patients (3475 mUS; 3615 mpMRI) were included. There was no significant difference between modalities in the detection of clinically significant prostate cancer (csPCa), both overall (RR 0.97; 95%CI 0.90–1.05) and with targeted biopsy (RR 1.05; 95%CI 0.97–1.14). Overall cancer detection was also comparable (RR 1.00; 95%CI 0.87–1.15), as was Grade Group 1 prostate cancer detection, whether assessed across all biopsies (RR 1.00; 95%CI 0.72–1.39) or with targeted biopsy alone (RR 0.90; 95%CI 0.64–1.27). Weighted pooled values showed mUS had a sensitivity of 93.2%, specificity of 23.3%, positive predictive value (PPV) of 46.4%, and negative predictive value (NPV) of 81.2%, compared with mpMRI’s sensitivity of 87.5%, specificity of 25.7%, PPV of 44.6%, and NPV of 73.7%. Conclusion mUS-guided biopsy demonstrates diagnostic performance comparable to mpMRI-guided biopsy for PCa detection and represents a promising alternative or adjunct to mpMRI in prostate cancer diagnostic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMultiparametric Magnetic Resonance ImagingImage-Guided BiopsyProstateUltrasonography, InterventionalMaleHumans

Stichwörter der Autor:innen

BiopsyDetection ratesMicroultrasoundMultiparametric MRIProstate cancer

Autor:innen und Institutionen

  • Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2, Dublin, Ireland. niamhmoynagh21@rcsi.ie.
  • Department of Urology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland. niamhmoynagh21@rcsi.ie.
  • Department of Urology, Royal Perth Hospital, Perth, WA, Australia.
  • Northwell Health, New Hyde Park, Long Island, NY, USA.
  • Department of Urology, Lenox Hill Hospital, New York, NY, USA.
  • Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2, Dublin, Ireland.

Förderung

  • Royal College of Surgeons in Ireland

Zitieren

APA

Moynagh, N., Bruinsma, J., Mac Curtain, B. M., Calpin, G. G., Elfaki, M., Nikolenko, R., Deshwal, A., Clausen, N., Benour, A., Qian, W., Temperley, H. C., Lawlor, P., Keane, J., Cozman, C., Yap, L. C., & Daly, P. J. (2026). Micro-ultrasound guided versus multiparametric MRI-guided prostate biopsy: a systematic review and meta-analysis. International Urology and Nephrology, 58(12), 5131-5141. https://doi.org/10.1007/s11255-026-05227-9

Vancouver

Moynagh N, Bruinsma J, Mac Curtain BM, Calpin GG, Elfaki M, Nikolenko R, et al. Micro-ultrasound guided versus multiparametric MRI-guided prostate biopsy: a systematic review and meta-analysis. International Urology and Nephrology. 2026;58(12):5131-5141. doi:10.1007/s11255-026-05227-9

BibTeX
@article{Moynagh2026,
  author = {Moynagh, Niamh and Bruinsma, Josh and Mac Curtain, Benjamin M and Calpin, Gavin G and Elfaki, Mohamed and Nikolenko, Rostyslav and Deshwal, Avinash and Clausen, Nicholas and Benour, Ali and Qian, Wanyang and Temperley, Hugo C and Lawlor, Peter and Keane, John and Cozman, Claudiu and Yap, Lee Chien and Daly, Padraig J},
  title = {Micro-ultrasound guided versus multiparametric MRI-guided prostate biopsy: a systematic review and meta-analysis},
  journal = {International Urology and Nephrology},
  year = {2026},
  volume = {58},
  number = {12},
  pages = {5131--5141},
  doi = {10.1007/s11255-026-05227-9}
}
Kostenlos starten →